MULTICENTER PROBE STUDY-4; COMPARISON OF THE EFFECTS OF ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS

Trial Profile

MULTICENTER PROBE STUDY-4; COMPARISON OF THE EFFECTS OF ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Apr 2017

At a glance

  • Drugs Azilsartan medoxomil (Primary) ; Olmesartan medoxomil (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms MUSCAT-4
  • Most Recent Events

    • 01 Apr 2017 Results comparing the practical efficacy of olmesartan with azilsartan on blood pressure, published in the Blood Pressure Monitoring
    • 06 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 07 Jan 2015 Status changed from recruiting to active, no longer recruiting, as reported by University Hospital Medical Information Network - Japan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top